相关实验视频
Updated: May 3, 2026

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair
Published on: February 3, 2017
过度表达GIPC1可以防止病态心脏重塑
Xi Sun1, Yanna Han2, Yahan Yu2
1Department of Pharmacology (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Harbin, China; Translational Medicine Research and Cooperation Center of Northern China, Heilongjiang Academy of Medical Sciences, Harbin, China; Department of Scientific Research, The Fourth Affiliated Hospital, Harbin Medical University, Harbin, China.
G-alpha相互作用蛋白C端1 (GIPC1) 通过稳定β1-上腺体受体来保护心脏. 过度表达GIPC1减少心脏重塑和功能障碍,这表明它是心力衰竭的治疗点.
科学领域:
- 心脏病学 心脏病学
- 分子生物学分子生物学
- 生物化学 生化学
背景情况:
- 病态心脏重塑,包括缩和纤维化,是心力衰竭的关键驱动因素,治疗选择有限.
- β-上腺素受体对于心脏功能调节至关重要.
- G-α相互作用蛋白 C-终端1 (GIPC1) 与β1-上腺素受体相互作用,但其在心脏功能中的作用基本上是未知的.
研究的目的:
- 研究GIPC1在心脏重塑中的作用.
- 阐明GIPC1在心脏中的功能的潜在分子机制.
主要方法:
- 在小鼠中使用异上腺素或横向大动脉收缩诱导心脏重塑.
- 使用心肌细胞特异性GIPC1条件淘汰 (cKO) 和腺相关病毒9 (AAV9) 介导的GIPC1过度表达的小鼠模型.
- 进行了心声学,组织学和生物化学分析,以评估心脏功能和重塑.
主要成果:
- 在心脏重塑模型中,GIPC1表达减少.
- GIPC1 cKO小鼠表现出自发性心脏缩,纤维化和缩功能障碍.
- 通过稳定β1-上腺素受体表达,平衡β1/β2-上腺素受体信号,并抑制MAPK通路,减弱了GIPC1过度表达的异上腺素诱导的心脏重塑.
结论:
- GIPC1在病态心脏重塑中表现出心脏保护作用.
- GIPC1代表了治疗心脏重塑和心力衰竭的潜在治疗标.
更多相关视频
09:16Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
Published on: June 3, 2018
05:04In vitro Assessment of Cardiac Reprogramming by Measuring Cardiac Specific Calcium Flux with a GCaMP3 Reporter
Published on: February 22, 2022
相关概念视频
Abnormal Proliferation
GPCR Desensitization
G-Protein Gated Ion Channels
Sensory...
GPCRs Regulate Adenylyl Cylase Activity
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy